nevirapine has been researched along with Chronic Disease in 7 studies
Nevirapine: A potent, non-nucleoside reverse transcriptase inhibitor used in combination with nucleoside analogues for treatment of HIV INFECTIONS and AIDS.
nevirapine : A dipyridodiazepine that is 5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepine which is substituted by methyl, oxo, and cyclopropyl groups at positions 4, 6, and 11, respectively. A non-nucleoside reverse transcriptase inhibitor with activity against HIV-1, it is used in combination with other antiretrovirals for the treatment of HIV infection.
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Excerpt | Relevance | Reference |
|---|---|---|
| "In a setting of high perinatal nevirapine use, acute chorioamnionitis was not associated with vertical HIV-1 transmission." | 5.12 | Acute and chronic chorioamnionitis and the risk of perinatal human immunodeficiency virus-1 transmission. ( Chi, BH; Goldenberg, RL; Levy, J; Mudenda, V; Sinkala, M; Stringer, JS, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (85.71) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Mechi, A | 1 |
| Al-Khalidi, A | 1 |
| Al-Darraji, R | 1 |
| Al-Dujaili, MN | 1 |
| Al-Buthabhak, K | 1 |
| Alareedh, M | 1 |
| Shaghee, F | 1 |
| Nafakhi, H | 1 |
| Neto, FR | 1 |
| Dorneles, JR | 1 |
| Carneiro Leão Veloso, JH | 1 |
| Gonçalves, CW | 1 |
| Gomes Costa, RR | 1 |
| Velaer, KN | 1 |
| Welk, B | 1 |
| Ginsberg, D | 1 |
| Myers, J | 1 |
| Shem, K | 1 |
| Elliott, C | 1 |
| Shi, Y | 1 |
| Meng, D | 1 |
| Wang, S | 1 |
| Geng, P | 1 |
| Xu, T | 1 |
| Zhou, Q | 1 |
| Zhou, Y | 1 |
| Li, W | 2 |
| Chen, X | 1 |
| Wakene, W | 1 |
| Asmamaw, S | 1 |
| Kahaliw, W | 1 |
| Zenebe, E | 1 |
| Washo, A | 1 |
| Addis Gesese, A | 1 |
| Halley, E | 1 |
| Giai, J | 1 |
| Chappuis, M | 1 |
| Tomasino, A | 1 |
| Henaine, R | 1 |
| Letrilliart, L | 1 |
| Nikolaus, S | 1 |
| Wittsack, HJ | 1 |
| Antke, C | 1 |
| Beu, M | 1 |
| Hautzel, H | 1 |
| Decheva, C | 1 |
| Mamlins, E | 1 |
| Mori, Y | 1 |
| Huston, JP | 1 |
| Antoch, G | 1 |
| Müller, HW | 1 |
| Li, R | 1 |
| Qi, Y | 1 |
| Shi, L | 1 |
| Wang, W | 3 |
| Zhang, A | 1 |
| Luo, Y | 1 |
| Kung, WK | 1 |
| Jiao, Z | 1 |
| Liu, G | 1 |
| Li, H | 1 |
| Zhang, L | 1 |
| Dalkner, N | 1 |
| Bengesser, SA | 1 |
| Birner, A | 1 |
| Fellendorf, FT | 1 |
| Fleischmann, E | 1 |
| Großschädl, K | 1 |
| Lenger, M | 1 |
| Maget, A | 1 |
| Platzer, M | 1 |
| Queissner, R | 1 |
| Schönthaler, E | 1 |
| Tmava-Berisha, A | 1 |
| Reininghaus, EZ | 1 |
| Guo, Y | 1 |
| Sun, Y | 1 |
| Song, Z | 1 |
| Zheng, W | 1 |
| Xiong, W | 1 |
| Yang, Y | 2 |
| Yuan, L | 1 |
| Deng, H | 1 |
| Chiu, PY | 1 |
| Wei, CY | 1 |
| Hung, GU | 1 |
| Wu, SL | 1 |
| Zhang, Y | 1 |
| Qi, Z | 1 |
| Wang, L | 1 |
| Cao, F | 1 |
| Zhao, L | 1 |
| Fang, X | 1 |
| Lu, Y | 1 |
| Chen, H | 1 |
| Zhang, J | 2 |
| Tang, B | 1 |
| Zhang, H | 1 |
| Ma, C | 1 |
| Tang, X | 1 |
| Li, L | 1 |
| Wu, J | 1 |
| Wei, J | 1 |
| Li, S | 1 |
| Yang, L | 1 |
| Han, L | 1 |
| Lu, C | 1 |
| Ma, L | 1 |
| Jin, G | 1 |
| Yao, K | 1 |
| Chang, R | 1 |
| Liu, J | 1 |
| Zhu, Z | 1 |
| Jin, X | 1 |
| Yin, J | 1 |
| Zhu, H | 1 |
| Yu, K | 1 |
| Liu, M | 1 |
| Zhang, X | 1 |
| Lu, M | 1 |
| Wan, Z | 1 |
| Huang, X | 2 |
| Li, X | 1 |
| Hu, S | 1 |
| Liu, Y | 1 |
| Huang, J | 1 |
| Hong, W | 1 |
| Xu, L | 1 |
| Xu, H | 1 |
| Fang, J | 1 |
| Kulikov, A | 1 |
| Shipaeva, E | 1 |
| Dmitrieva, A | 1 |
| Batrak, V | 1 |
| Shipunov, G | 1 |
| Guy, C | 1 |
| Smith, J | 1 |
| Zhang, R | 1 |
| Zhang, M | 1 |
| Duan, J | 1 |
| Chestukhin, A | 1 |
| Barbashov, S | 1 |
| Samsonov, M | 1 |
| Lavrovsky, Y | 1 |
| Qu, Q | 1 |
| Cui, W | 1 |
| Xing, X | 1 |
| Zou, R | 1 |
| Wang, X | 1 |
| Wu, T | 1 |
| Bello-Onaghise, G | 1 |
| Yuan, S | 1 |
| Li, Y | 1 |
| Li, T | 1 |
| Wang, PJ | 1 |
| Zhang, ZW | 1 |
| Huang, JQ | 1 |
| Elzayat, MT | 1 |
| Markofski, MM | 1 |
| Simpson, RJ | 1 |
| Laughlin, M | 1 |
| LaVoy, EC | 1 |
| de Maat, MM | 1 |
| Beijnen, JH | 1 |
| Schellens, JH | 1 |
| Mulder, JW | 1 |
| Weinberg, WG | 1 |
| Chi, BH | 1 |
| Mudenda, V | 1 |
| Levy, J | 1 |
| Sinkala, M | 1 |
| Goldenberg, RL | 1 |
| Stringer, JS | 1 |
| Baño Rodrigo, MD | 1 |
| Agujetas Rodríguez, M | 1 |
| López García, ML | 1 |
| Guillén Llera, JL | 1 |
| Ware, AJ | 1 |
| Moore, T | 1 |
1 trial available for nevirapine and Chronic Disease
| Article | Year |
|---|---|
Acute and chronic chorioamnionitis and the risk of perinatal human immunodeficiency virus-1 transmission.
Topics: Acute Disease; Adult; Anti-HIV Agents; Chorioamnionitis; Chronic Disease; Female; Fetal Blood; HIV I | 2006 |
6 other studies available for nevirapine and Chronic Disease
| Article | Year |
|---|---|
Topics: Adolescent; Adult; Aged; Animals; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Area Under | 2022 |
Chronic hepatotoxicity after long-term antiretroviral treatment including nevirapine.
Topics: Adult; Anti-HIV Agents; Chemical and Drug Induced Liver Injury; Chronic Disease; HIV Infections; Hum | 2005 |
Nevirapine absorbed well despite chronic diarrhea.
Topics: Adult; Anti-HIV Agents; Chronic Disease; Diarrhea; HIV Infections; HIV-1; Humans; Intestinal Absorpt | 2005 |
[Nevirapine induces abstinence symptoms in patients on a methadone maintenance program with HIV infection].
Topics: Adult; Analysis of Variance; Anti-HIV Agents; Chronic Disease; Drug Interactions; Drug Therapy, Comb | 2000 |
Resolution of chronic parvovirus b19-induced anemia, by use of highly active antiretroviral therapy, in a patient with acquired immunodeficiency syndrome.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiretroviral Therapy, Highly Active | 2001 |
Rwanda to receive cheaper anti-HIV drugs for chronic treatment and free viramune to prevent viral transmission from mother to child.
Topics: Anti-HIV Agents; Chronic Disease; Developing Countries; Drug Costs; Drug Industry; Female; HIV Infec | 2001 |